HLA-G and cancer: HLA-G overexpression happens in cancer context to avoid immunological recognition (27) and Grange et al demonstrated that HLA-G carried by EVs is capable of performing immunomodulatory processes, such as inhibiting the maturation of dendritic cells induced by renal cancer stem cells (20).